- Report
- October 2023
- 138 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- October 2023
- 138 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- September 2023
- 139 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- June 2023
- 140 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- May 2023
- 144 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- May 2024
- 193 Pages
Global
From €4770EUR$4,950USD£4,103GBP
- Report
- November 2023
- 175 Pages
Global
From €4818EUR$5,000USD£4,144GBP
- Report
- May 2024
- 193 Pages
Global
From €5252EUR$5,450USD£4,517GBP
- Report
- February 2024
- 110 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- February 2024
- 111 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- February 2024
- 120 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- February 2024
- 112 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- August 2023
- 182 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- November 2023
- 30 Pages
Global
From €2650EUR$2,750USD£2,279GBP
- Report
- July 2023
- 128 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- February 2024
- 182 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- February 2024
- 176 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- February 2024
- 181 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- January 2024
- 172 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- November 2023
- 180 Pages
Global
From €4722EUR$4,900USD£4,061GBP
The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more